MoneyWorks4Me

IOL Chemicals & Pharmaceuticals informs about disclosure of impact of covid-19

17 Jul 2020 Evaluate

Pursuant to Regulation 30 of Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CMDl/CIR/P/2020/84 dated 20th May 2020, IOL Chemicals & Pharmaceuticals has informed about disclosure of material impact of COVID-19 pandemic under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


IOL Chem & Pharma Share Price

165.95 2.15 (1.31%)
21-Aug-2026 11:58 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1890.40
Dr. Reddys Labs. 1176.90
Cipla 1425.00
Lupin 2197.80
Zydus Lifesciences 1103.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: